4.5 Article

Switching under selection: how CoREST controls endocrine therapy resistance in ER+ breast cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Endocrine resistance and breast cancer plasticity are controlled by CoREST

Liliana Garcia-Martinez et al.

Summary: This study demonstrates the important role of the CoREST complex in endocrine resistance and ER+ breast cancer plasticity, and suggests it as a potential therapeutic target for advanced breast cancer treatment.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2022)

Article Biochemistry & Molecular Biology

H3K27ac mediated SS18/BAFs relocation regulates JUN induced pluripotent-somatic transition

Runxia Lin et al.

Summary: This study investigates the key events in early mammalian embryonic development using a JUN-induced pluripotent-somatic transition (PST) model. The results reveal a rapid transfer of chromatin remodeling complexes from pluripotent loci to somatic loci during PST, facilitating chromatin opening and gene activation.

CELL AND BIOSCIENCE (2022)

Review Multidisciplinary Sciences

Epigenetic mechanisms in breast cancer therapy and resistance

Liliana Garcia-Martinez et al.

Summary: The majority of breast cancers express the estrogen receptor and endocrine therapy has been the mainstay for hormone-responsive breast cancer treatment. Recent studies have shown the importance of the epigenome in determining hormone therapy response and how targeting epigenetic factors can help overcome clinical resistance. Understanding epigenetic mechanisms regulating ER+ breast cancer and endocrine therapy resistance is crucial for improving targeted therapies for this type of cancer.

NATURE COMMUNICATIONS (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Multidisciplinary Sciences

LSD1-mediated enhancer silencing attenuates retinoic acid signalling during pancreatic endocrine cell development

Nicholas K. Vinckier et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4

Fangjian Gao et al.

MOLECULAR CELL (2019)

Article Biochemistry & Molecular Biology

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer

Darren K. Patten et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors

Jay H. Kalin et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

The prognostic effects of somatic mutations in ER-positive breast cancer

Obi L. Griffith et al.

NATURE COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

AP-1 Transcription Factors and the BAF Complex Mediate Signal-Dependent Enhancer Selection

Thomas Vierbuchen et al.

MOLECULAR CELL (2017)